Home » Stocks » ATRX » Financials

Adhera Therapeutics, Inc. (ATRX)

Stock Price: $0.1000 USD 0.0000 (0.00%)
Updated Jul 23, 2021 3:30 PM EDT - Market closed

Income Statement (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201120102009200820072006
Revenue-0.250.08---0.502.124.222.242.4614.732.6118.1428.49
Revenue Growth-231.58%-----76.36%-49.85%88.6%-9.11%-83.3%464.66%-85.62%-36.34%-
Cost of Revenue-0.410.28---------2.910.100.36
Gross Profit--0.16-0.21---0.502.124.222.242.4614.73-0.3018.0428.14
Selling, General & Admin2.049.979.844.730.580.613.331.775.258.3710.3610.0913.6220.3114.21
Research & Development--0.240.910.130.320.690.725.1711.4418.1114.8836.7752.2543.24
Other Operating Expenses0.001.195.510.450.050.180.000.001.6817.423.530.468.260.000.00
Operating Expenses2.0411.1615.596.090.761.114.022.4812.1037.2331.9925.4358.6572.5757.45
Operating Income-2.04-11.32-15.80-6.09-0.76-1.11-3.52-0.37-7.88-35.00-29.53-10.69-58.94-54.53-29.32
Interest Expense / Income1.770.660.040.080.000.001.010.251.72-2.830.540.801.150.64
Other Expense / Income-0.050.000.920.050.080.001.951.00-0.09-6.71-4.60-3.19-0.52-3.31-3.08
Pretax Income-3.77-11.98-16.76-6.22-0.84-1.11-6.48-1.61-9.51-28.28-27.75-8.05-59.22-52.37-26.88
Income Tax---0.000.000.00--0.040.041.14-----
Net Income-3.77-11.98-16.76-6.22-0.84-1.11-6.48-1.57-9.55-29.42-27.75-8.05-59.22-52.37-26.88
Preferred Dividends1.541.501.06---6.00--------
Net Income Common-5.31-13.48-17.82-6.22-0.84-1.11-12.48-1.57-9.55-29.42-27.75-8.05-59.22-52.37-26.88
Shares Outstanding (Basic)10.8810.8410.849.8447.432.922.461.691.340.630.180.090.070.060.05
Shares Outstanding (Diluted)10.8810.8410.849.8447.432.922.461.691.340.630.180.090.070.060.05
Shares Change0.33%0.02%10.19%-79.26%1524.66%18.51%45.44%26.24%112.01%260.18%87.63%26.84%18.14%17.8%-
EPS (Basic)-0.49-1.24-1.64-0.63-0.02-0.38-5.10-0.90-7.10-46.50-158.00-86.00-804.00-840.00-508.00
EPS (Diluted)-0.49-1.24-1.64-0.63-0.02-0.38-5.10-0.90-7.10-46.50-158.00-86.00-804.00-840.00-508.00
Free Cash Flow Per Share-0.05-0.81-0.89-0.13-0.01-0.25-1.940.19-2.95-25.47-97.92-68.99-541.21-807.69-470.39
Gross Margin--62.3%-273.7%---100%100%100%100%100%100%-11.4%99.4%98.8%
Operating Margin--4,490.5%-20,782.9%----704.0%-17.3%-186.9%-1,565.1%-1,200.4%-72.6%-2,259.2%-300.7%-102.9%
Profit Margin--5348.8%-23446.1%----2495.4%-74.3%-226.4%-1315.9%-1128.2%-54.6%-2269.8%-288.8%-94.3%
FCF Margin--3,467.5%-12,743.4%----955.8%14.9%-93.9%-720.9%-699.4%-43.9%-1,531.4%-278.3%-87.6%
EBITDA-1.99-11.23-16.39-5.69-0.78-1.11-5.47-1.36-7.24-27.03-23.35-5.14-54.31-46.83-23.33
EBITDA Margin--4457.9%-21559.2%----1094.2%-64.3%-171.6%-1208.9%-949%-34.9%-2081.6%-258.2%-81.9%
EBIT-1.99-11.32-16.72-6.14-0.83-1.11-5.47-1.36-7.79-28.28-24.93-7.51-58.42-51.22-26.24
EBIT Margin--4,490.5%-21,997.4%----1,094.2%-64.3%-184.8%-1,264.8%-1,013.3%-51.0%-2,239.3%-282.4%-92.1%

Showing 15 of 26 years

11 more years are available